 ALISO VIEJO, Calif., Aug. 10, 2021 GLOBE NEWSWIRE -- RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as of the closing of the Companys initial public offering on August 3, 2021. The three appointments, including Robert Bob Palmisano, Robert Warner and Julie Andrews, joined directors J. Andy Corley, William J. Link, Ph.D., Juliet Tammenoms Bakker and Ron M. Kurtz, M.D. Concurrent with the new appointments, the Company announced the resignations of four long-serving board members Bruce Robertson, Ph.D., Daniel Schwartz, M.D., Christopher Cox, and Rick Wolfen. 